CTTC
-
Center for Technology Transfer & Commercialization breaks records in rapid facilitation of COVID-19 related agreements
To keep pace with Vanderbilt researchers developing COVID-19 solutions, the Center for Technology Transfer & Commercialization has facilitated three license agreements, 11 patent applications and 43 material transfer agreements in record time. Read MoreJul 9, 2020
-
Vanderbilt ranks 36th on NAI’s Top 100 list for U.S. patents
Vanderbilt University is ranked 36th in a 2019 U.S. patents report released by the by the National Academy of Inventors and the Intellectual Property Owners Association. Read MoreJul 6, 2020
-
Robot prototype shows promise for microsurgery on eyes and aneurysms
A new continuum robot designed by Vanderbilt engineers achieves multiscale motion and may open up a huge world of previously impossible complex microsurgeries. Read MoreNov 14, 2019
-
Biophotonics device for parathyroid I.D. is a R&D 100 Awards finalist
An optical imaging technology developed by Orrin H. Ingram Professor of Biomedical Engineering Anita Mahadevan-Jansen and her group, in partnership with a medical device company, has been selected as a finalist for the 2019 R&D 100 Awards. Read MoreOct 28, 2019
-
Soldiers partner with Vanderbilt engineers to create new model for innovation
Soldiers from the 3rd Brigade Combat Team of the 101st Airborne Division at Fort Campbell, Kentucky, and researchers at Vanderbilt's School of Engineering are building a partnership to identify and solve tactical problems with soldier-inspired solutions. Read MoreOct 21, 2019
-
Hand-held robot points to less invasive prostate surgery
Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options. Read MoreJul 18, 2019
-
Hand-held robot points to less invasive prostate surgery
Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options. A key part of the design – telescoping, curved, concentric tubes – received U.S. patent protection in March 2019, the same month the principal investigators secured a $2.1 million R01... Read MoreJul 18, 2019
-
Ancora Innovation proposal submissions open March 14
This is the second request for proposals to Ancora since Vanderbilt and Deerfield launched their collaboration in 2018 with a commitment from Deerfield of up to $65 million in initial funding over five years to support promising drug discovery research. Read MoreFeb 26, 2019
-
Therapeutic Antibody Discovery and Development event is Jan. 23
Vanderbilt's Center for Technology Transfer and Commercialization, the Vanderbilt Institute of Chemical Biology and Deerfield will bring together experts in discovery and development of antibody therapeutics Jan. 23 to discuss and review state-of-the-art developments in the field. Read MoreJan 2, 2019
-
Therapeutic Antibody Discovery and Development event is Jan. 23
The event aims to expose faculty and staff to therapeutic antibody discovery in an academic setting and foster interest in submission of innovative ideas for antibody targets through an upcoming RFP for Ancora, the collaboration between Vanderbilt and Deerfield. Read MoreDec 19, 2018
-
FDA approves device based on Vanderbilt invention to ID parathyroid during head and neck surgeries
Ten years after Professor of Biomedical Engineering Anita Mahadevan-Jansen discovered that parathyroid tissues glow under near-infrared light, the FDA has approved a device based on the technology for surgical use. Read MoreDec 17, 2018
-
Ancora announces major funding awards to support Vanderbilt drug discovery research
Ancora Innovation, LLC, the new collaboration between Vanderbilt and Deerfield Management established earlier this year, has completed its inaugural proposal review process and announced two projects selected for funding. Read MoreNov 26, 2018
-
Business Valuation Seminar 2018 at Wond’ry Nov. 7
Nashville-based valuation expert Glenn Perdue will lead a seminar on the valuation process of early-stage businesses on Wednesday, Nov. 7, at the Wond'ry. Read MoreOct 19, 2018
-
CTTC to host session on funding opportunities for physicians, scientists developing new therapies
Vanderbilt's Center for Technology Transfer and Commercialization will host a session on Oct. 16 with the Harrington Discovery Institute to explore funding opportunities for physicians and scientists who are developing new therapies. Read MoreOct 7, 2018
-
Slides can help faculty with Ancora proposal submissions
The Office of the Vice Provost for Research and the Center for Technology Transfer and Commercialization have posted informational slides for faculty preparing pre-proposal submissions in response to the inaugural Ancora request for proposals. Read MoreMay 10, 2018
-
Ancora inaugural request for proposals announced
The Office of the Vice Provost for Research and Deerfield Management announce the inaugural request for proposals for Ancora Innovation, LLC, with a due date of June 4. An RFP information session is scheduled from 2 to 3:30 p.m. Friday, April 27, at Sarratt Student Center, Room 325. Read MoreApr 20, 2018
-
‘Collaborating with industry to advance basic science research’ topic of April 6 talk
The Center for Technology Transfer and Commercialization's Alan Bentley will discuss emerging initiatives at Vanderbilt to engage industry more effectively, and a team from Deerfield Management will explain its collaborative approach to working with premier academic institutions to catalyze early stage therapeutic development. Read MoreApr 4, 2018
-
Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer
New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers. Read MoreMar 14, 2018
-
Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment
Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia. Read MoreJan 8, 2018
-
Vanderbilt is No. 10 in Thomson Reuters’ ‘World’s Most Innovative Universities’
The ranking is based on a number of indicators, including patent filings and research paper citations. Read MoreSep 28, 2017